Longevity
Human Continuum raises $5.1m to advance exosome platform
New funding will support development of regenerative therapies and diagnostics aimed at extending healthspan. A growing number of longevity companies are foreseeing that the future of medicine lies not only in treating disease, but in helping the body repair itself. Human Continuum is the latest to attract investor backing for that vision. The company announced […] The post Human Continuum raises $5.1m to advance exosome platform appeared first on Longevity.Technology .
This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.
Read full coverage at Longevity.Technology →